Evidence map›Paper›PMID 34385337›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2022

Blind Image Restoration Enhances Digital Autoradiographic Imaging of Radiopharmaceutical Tissue Distribution.

Lu Peng, Benabdallah Nadia, Jiang Wen, Brian W Simons, Zhang Hanwen, Robert F Hobbs, Ulmert David, Brian C Baumann, Russell K Pachynski, Abhinav K Jha and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Beyond Average: α-Particle Distribution and Dose Heterogeneity in Bone Metastatic Prostate Cancer.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2024
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Lu PengDepartment of Biomedical Engineering, Washington University in St. Louis, St. Louis, Missouri.
Benabdallah NadiaDepartment of Radiology, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri.
Jiang WenProgram in Quantitative Molecular Therapeutics, Washington University School of Medicine, St. Louis, Missouri.
Brian W SimonsCenter for Comparative Medicine, Baylor College of Medicine, Houston, Texas.
Zhang HanwenDepartment of Radiology, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri.
Robert F HobbsRadiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Ulmert DavidDepartment of Molecular and Medical Pharmacology, UCLA, Los Angeles, California.
Brian C BaumannDepartment of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri.
Russell K PachynskiDivision of Oncology, Washington University School of Medicine, St. Louis, Missouri; and.
Abhinav K JhaDepartment of Biomedical Engineering, Washington University in St. Louis, St. Louis, Missouri.
Daniel L J ThorekDepartment of Biomedical Engineering, Washington University in St. Louis, St. Louis, Missouri; thorekd@wustl.edu.
Washington University in St. Louis · USMallinckrodt (United States) · USBaylor College of Medicine · USJohns Hopkins University · USUniversity of California, Los Angeles · US

Funding

The Radium-223 Combination Therapy Space; Improving Response and Clarifying ToxicitiesR01CA240711 · NCI · WASHINGTON UNIVERSITY · PI MICHALSKI, JEFF M., THOREK, DANIEL LYNDON JAFFE · 2020 to 2024
$2.2M
Opening the Therapeutic Window for PSMA-Targeted Molecular RadiotherapyR01CA229893 · NCI · WASHINGTON UNIVERSITY · PI THOREK, DANIEL LYNDON JAFFE · 2019 to 2024
$1.9M
Kallikrein-Targeted Alpha-Particle Therapy of Late-Stage Prostate CancerR01CA201035 · NCI · WASHINGTON UNIVERSITY · PI THOREK, DANIEL LYNDON JAFFE · 2017 to 2020
$1.4M
NCI NIH HHS R01 CA201035NCI NIH HHS R01 CA229893NCI NIH HHS R01 CA240711
6 · The paper itself

Abstract

Digital autoradiography (DAR) is a powerful tool to quantitatively determine the distribution of a radiopharmaceutical within a tissue section and is widely used in drug discovery and development. However, the low image resolution and significant background noise can result in poor correlation, even errors, between radiotracer distribution, anatomic structure, and molecular expression profiles. Differing from conventional optical systems, the point-spread function in DAR is determined by properties of radioisotope decay, phosphor, and digitizer. Calibration of an experimental point-spread function a priori is difficult, prone to error, and impractical. We have developed a content-adaptive restoration algorithm to address these problems.

Indexed as

Diagnostic ImagingRadiopharmaceuticalsAlgorithmsAnimalsAutoradiographyFluorodeoxyglucose F18HumansImage Processing, Computer-AssistedMaleMicePhantoms, ImagingTissue DistributionFluorodeoxyglucose F18Radiopharmaceuticalsblind image restorationdigital autoradiographyPoisson–gaussian noise modelpositronα-particle emission

Identifiers

PMID34385337
PMCPMC8973285
OpenAlexW3192569078

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.